HOPKINSON CRAIG C. (EVP R&D, Chief Medical Officer) sold 10.9% of their position (9K shares) of ALKERMES PLC. on the open market
Open‑market sale worth $463.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/1/2026ACC: 0001520262-26-000103
Officer· EVP R&D, Chief Medical Officer
Since Mar 2026
-9K
Net shares
Net seller
$463.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 14K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+5K
Price / share
$19.34
Trade value
$96.70K
% of position
6.5%
7/1/2026
77.39K→82.39K
Ordinary Shares
Direct
Shares
−8.30K
Price / share
$51.46
Trade value
$427.13K
% of position
10.1%
7/1/2026
82.39K→74.09K
Ordinary Shares
Direct
Shares
−700.00
Price / share
$52.13
Trade value
$36.49K
% of position
0.9%
7/1/2026
74.09K→73.39K
Total
Net shares
−4K
Net value
-$366.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/1/2026 | M · Option Exercise | +5K | $19.34 | $96.70K | 6.5% | 77.39K | 82.39K |
| Ordinary Shares Direct | 7/1/2026 | S · Sale | −8.30K | $51.46 | $427.13K | 10.1% | 82.39K | 74.09K |
| Ordinary Shares Direct | 7/1/2026 | S · Sale | −700.00 | $52.13 | $36.49K | 0.9% | 74.09K | 73.39K |
| Total | −4K | -$366.92K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
5K shares
Shares
−5K
Strike price
19.34
Held after
1.36K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares5K shares | 7/1/2026 | M · Option Exercise | −5K | 19.34 | — | 1.36K |